Rahsaan Thompson's Net Worth
Estimate Recalculated Nov 4, 2024 02:36AM EST
Who is Rahsaan Thompson
Rahsaan Thompson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Gritstone Oncology, Inc., OPIANT PHARMACEUTICALS, INC., Lyell Immunopharma, Inc., and ZEVRA THERAPEUTICS, INC..
SEC CIK
Rahsaan Thompson's CIK is 0001788524
Past Insider Trading and Trends
2022 was Rahsaan Thompson's most active year for acquiring shares with 3 total transactions. Rahsaan Thompson's most active month to acquire stocks was the month of December. 2022 saw Rahsaan Thompson paying a total of $0.00 for 849,680 shares, this is the most they've acquired in one year.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
